Financial reports
10-Q
2024 Q1
Quarterly report
9 May 24
10-K
2023 FY
Annual report
29 Feb 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
31 Jul 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
23 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
Current reports
8-K
Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
9 May 24
8-K
Submission of Matters to a Vote of Security Holders
1 May 24
8-K
Other Events
22 Apr 24
8-K
Regulation FD Disclosure
15 Apr 24
8-K
Other Events
12 Mar 24
8-K
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
29 Feb 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments
14 Nov 23
8-K
Other Events
5 Oct 23
8-K
Other Events
2 Oct 23
Registration and prospectus
S-8
Registration of securities for employees
9 May 24
424B5
Prospectus supplement for primary offering
19 Apr 24
424B5
Prospectus supplement for primary offering
17 Apr 24
424B7
Prospectus with selling stockholder info
12 Mar 24
424B5
Prospectus supplement for primary offering
4 Oct 23
424B5
Prospectus supplement for primary offering
2 Oct 23
424B5
Prospectus supplement for primary offering
2 Oct 23
S-3ASR
Automatic shelf registration
2 Oct 23
S-8
Registration of securities for employees
12 May 23
424B4
Prospectus supplement with pricing info
24 Oct 22
Other
EFFECT
Notice of effectiveness
21 Oct 22
CORRESP
Correspondence with SEC
18 Oct 22
CORRESP
Correspondence with SEC
18 Oct 22
UPLOAD
Letter from SEC
18 Oct 22
SEC STAFF ACTION
SEC staff action: Order
22 Sep 22
CERT
Certification of approval for exchange listing
20 Sep 22
CORRESP
Correspondence with SEC
20 Sep 22
CORRESP
Correspondence with SEC
14 Sep 22
UPLOAD
Letter from SEC
13 Sep 22
CORRESP
Correspondence with SEC
24 Aug 22